CT angiography compared to invasive angiography for stable coronary disease as predictors of Major Adverse Cardiovascular Events- a systematic review and meta-analysis

Corballis, Natasha, Tsampasian, Vasiliki, Merinopoulis, Ioannis, Gunawardena, Tharusha, Bhalraam, Raam, Eccleshall, Simon, Dweck, Marc R. and Vassiliou, Vassilios (2023) CT angiography compared to invasive angiography for stable coronary disease as predictors of Major Adverse Cardiovascular Events- a systematic review and meta-analysis. Heart & Lung, 57. pp. 207-213. ISSN 0147-9563

[thumbnail of 1-s2.0-S014795632200228X-main]
Preview
PDF (1-s2.0-S014795632200228X-main) - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Background: Computational tomography coronary angiography (CTCA) is increasingly the diagnostic test of choice for investigating patients with stable anginal symptoms. Objectives: We sought to conduct a systematic review and meta-analysis comparing CTCA with invasive coronary angiography (ICA) with regards to major adverse cardiovascular events (MACE), procedural complications and rates of revascularisation. Methods: We conducted a systematic review and meta-analysis in line with the PRISMA statement. A literature search was conducted using PubMed, MEDLINE Ovid and Embase, with three studies included in meta-analysis. Statistical analysis was undertaken using Review Manager 5.3 for MacOS software and outcomes expressed as odds ratio, with 95% confidence intervals and sensitivity analysis was conducted. Results: A total of 5662 patients were included in this study level meta-analysis. There was no difference in MACE between CT and angiography [2.97% v 3.45%, fixed-effect model, OR: 0.84 (0.62–1.14), p = 0.26, I2 0%] and no difference found in rates of myocardial infarction, death or stroke. CTCA was associated with a reduced rate of revascularisation [12.6% v 18.3%, fixed-effects model, OR: 0.64 (0.55–0.75), p<0.00001, I2 =0%]. However, CTCA was not associated with a significantly lower complication rate [0.5% v 1.72%, random effects model, OR: 0.52 (0.06–4.38), p = 0.55, I2 52%]. Conclusion: CTCA is a safe strategy for investigating patients with stable angina with no associated increase in MACE but a reduction in revascularisation rates.

Item Type: Article
Additional Information: Funding Information: Dr Natasha Corballis and Dr Vasiliki Tsampasian are NIHR Academic Clinical Fellows. Dr Simon Eccleshall received funding for lectures and proctorship from B Braun, Medtronic and MedAlliance and funding for investigator-initiated research unrelated to this work from B Braun. Professor Dweck MRD is supported by the British Heart Foundation (FS/14/78/31020) and is the recipient of a Sir Jules Thorn Award for Biomedical Research 2015 (15/JTA). Professor Vassiliou receives funding for investigator initiated research unrelated to this work from B Braun and Medtronic. This work was partially supported by the Norfolk Heart Trust.
Uncontrolled Keywords: angina,ctca,invasive angiography,stable coronary disease,pulmonary and respiratory medicine,critical care and intensive care medicine,cardiology and cardiovascular medicine ,/dk/atira/pure/subjectarea/asjc/2700/2740
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Faculty of Science > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 29 Sep 2022 10:30
Last Modified: 06 Feb 2025 10:58
URI: https://ueaeprints.uea.ac.uk/id/eprint/88717
DOI: 10.1016/j.hrtlng.2022.09.018

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item